Authors:
Hernandez, JM
Martin, G
Gutierrez, NC
Cervera, J
Ferro, MT
Calasanz, MJ
Martinez-Climent, JA
Luno, E
Tormo, M
Rayon, C
Diaz-Mediavilla, J
Gonzalez, M
Gonzalez-San Miguel, JD
Perez-Equiza, K
Rivas, C
Esteve, J
Alvarez, MD
Odriozola, J
Ribera, JM
Sanz, MA
Citation: Jm. Hernandez et al., Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA, HAEMATOLOG, 86(8), 2001, pp. 807-813
Authors:
Urbano-Ispizua, A
Brunet, S
Solano, C
Moraleda, JM
Rovira, M
Zuazu, J
de la Rubia, J
Bargay, J
Caballero, D
Diez-Martin, JL
Ojeda, E
de Oteiza, JP
Ferra, C
Espigado, I
Alegre, A
de la Serna, J
Torres, P
Riu, C
Odriozola, J
Rozman, C
Sierra, J
Garcia-Conde, J
Montserrat, E
Citation: A. Urbano-ispizua et al., Allogeneic transplantation of CD34(+)-selected cells from peripheral bloodin patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation, BONE MAR TR, 28(4), 2001, pp. 349-354
Authors:
Villalon, L
Avello, AG
Cesar, J
Odriozola, J
Lopez, J
Oteyza, JP
Larana, JG
Cantalapiedra, A
Navarro, JL
Citation: L. Villalon et al., Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?, THROMB RES, 99(5), 2000, pp. 439-446
Authors:
Wiestner, A
Padosch, SA
Ghilardi, N
Cesar, JM
Odriozola, J
Shapiro, A
Skoda, RC
Citation: A. Wiestner et al., Hereditary thrombocythaemia is a genetically heterogenous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia, BR J HAEM, 110(1), 2000, pp. 104-109
Authors:
Steegmann, JL
Odriozola, J
Rodriguez-Salvanes, F
Giraldo, P
Garcia-Larana, J
Ferro, MT
Benitez, E
Perez-Pons, C
Giralt, M
Escribano, L
Lavilla, E
Miguel, A
Areal, C
Perez-Encinas, M
Abad, A
Maldonado, J
Massague, I
Fernandez-Ranada, JM
Citation: Jl. Steegmann et al., Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha 2a and CML, HAEMATOLOG, 84(11), 1999, pp. 978-987
Authors:
Parra, C
Roldan, E
Rodriguez, C
de Oteyza, JP
Oteho, E
Lopez, J
Maldonado, MS
Larana, JG
Munoz, A
Odriozola, J
Brieva, JA
Citation: C. Parra et al., Reconstitution of peripheral blood lymphocytes in patients submitted to bone marrow transplantation: comparison between allogeneic and autologous, MED CLIN, 113(1), 1999, pp. 1-5
Authors:
Facon, T
Harousseau, JL
Maloisel, F
Attal, M
Odriozola, J
Alegre, A
Schroyens, W
Hulin, C
Schots, R
Marin, P
Guilhot, F
Granena, A
De Waele, M
Pigneux, A
Meresse, V
Clark, P
Reiffers, J
Citation: T. Facon et al., Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirementsin multiple myeloma patients: A randomized, controlled trial, BLOOD, 94(4), 1999, pp. 1218-1225
Authors:
Perez-Oteyza, J
Bornstein, R
Corral, M
Hermosa, V
Alegre, A
Torrabadella, M
Ramos, P
Garcia, J
Odriozola, J
Navarro, JL
Citation: J. Perez-oteyza et al., Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: a prospective multicenter study, HAEMATOLOG, 83(11), 1998, pp. 1001-1005